Expertise in
5
conditions

Kye Y. Lee

Nung-dong, KR 
Expertise in
5
conditions
Nung-dong, KR 

Overview

Kye Lee practices practicing medicine in Nung-dong, Republic of Korea.

Mr. Lee is highly rated in 5 conditions, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Nung-dong, Republic of Korea
Other Locations
Seoul, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II, Multicenter Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR Mutation Positive Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Chemoradiation Therapy (PLATINUM Trial)
A Phase II, Multicenter Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR Mutation Positive Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Chemoradiation Therapy (PLATINUM Trial)
Enrollment Status: Unknown
Publish Date: September 01, 2023
Intervention Type: Drug
Study Phase: Phase 2
Retreatment With 1st Generation EGFR TKIs in Sensitizing EGFR Mutation Positive Non-Squamous Cell Carcinoma Patients Who Previously Treated With EGFR TKI and Cytotoxic Chemotherapy
Retreatment With 1st Generation EGFR TKIs in Sensitizing EGFR Mutation Positive Non-Squamous Cell Carcinoma Patients Who Previously Treated With EGFR TKI and Cytotoxic Chemotherapy
Enrollment Status: Unknown
Publish Date: July 15, 2021
Intervention Type: Drug
Study Drug: EGFR
Study Phase: Phase 2
A Phase II Study to Assess Efficacy of Pan-HER Inhibitor (HM781-36B, Poziotinib) in Stage IV Lung Adenocarcinoma With HER2 Mutation
A Phase II Study to Assess Efficacy of Pan-HER Inhibitor (HM781-36B, Poziotinib) in Stage IV Lung Adenocarcinoma With HER2 Mutation
Enrollment Status: Completed
Publish Date: May 24, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

64 Total Publications

Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP.
Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP.
Journal: Cancers
Published: June 30, 2025

Frequently Asked Questions about Kye Y. Lee

Is Kye Y. Lee a top-rated expert for EGFR Positive Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Kye Y. Lee is classified as an Distinguished expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kye Y. Lee participate in research or clinical trials?

Yes. Kye Y. Lee has published 64 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Kye Y. Lee's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lee's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile